TETRA Technologies Lowers Term Loan Rate and Extends Maturity to 2030
TETRA Technologies reduced its term loan interest rate to SOFR plus 5.00% and extended the maturity date to late 2030 to boost liquidity.
Every story explained in plain English, with the prices that matter beside it.
TETRA Technologies reduced its term loan interest rate to SOFR plus 5.00% and extended the maturity date to late 2030 to boost liquidity.
Atrium Therapeutics secures approximately $50 million in a private placement to advance its lead clinical programs and fund operations.
An international tribunal ruled Venture Global breached its supply agreement. Damages are capped at $170 million.
Regenerative Medical Technology Group added ten new tracks to its online academy, aiming to grow higher-margin, travel-independent education revenue.
Regenerative Medical Technology Group, Inc. expanded its ISSCA Online Academy with ten new tracks to scale digital education and reduce travel reliance.
Hon Hai subsidiary Fulian Yuzhan has leased a 74,491-square-meter factory building in Zhengzhou, China, to support its ongoing operational needs.
Precision BioSciences will deliver a late-breaking oral presentation on its PBGENE-HBV gene editing therapy at AASLD The Liver Meeting 2026.
Fitzroy Minerals Inc. raised approximately C$1.95 million after investors exercised all outstanding warrants early to fund Chile copper projects.
Medifast, Inc. presents data showing how its Trilivy program protects muscle and uses coaching to help clients maintain long-term weight loss.
Gogo Inc. signed a satellite connectivity lease worth over $15 million with a sovereign customer, validating its government segment demand.
Alternative Ballistics Corp launched a direct-to-consumer website for its less-lethal product, transitioning from development to active commercial sales.
Eureka Metals Corp. detected scandium in nearly all 2026 samples at its Tyee project, pointing to a potential new by-product stream.
Wisr AI Systems has listed its RiskAssure platform on Merchant Growth's marketplace, opening a distribution channel to over 15,000 small businesses.
Cullinan Therapeutics has dosed the first patient in a pivotal Phase 2 trial of CLN-049 for patients with relapsed or refractory acute myeloid leukemia.
First Majestic Silver Corp. posted its Q3 2026 production results and announced a renewal of its share repurchase program amid labor issues at San Dimas.
Henry Schein, Inc. appointed Emmanuel Caprais as CFO starting November 4, 2026, as the company targets technology and strategic transformation.
Glaukos Corporation has licensed a new retinal drug candidate and platform from RevOpsis, expanding its pipeline into major eye diseases.
Beamr Imaging expects fiscal 2026 revenue to rise 50% YoY, driven by license renewals, new partnerships, and progress in autonomous vehicle technology.
Omai Gold Mines Corp. is adding a sixth drill to accelerate its 5,000-meter gold exploration program near existing deposits in Guyana.
Aclarion, Inc. broadened enrollment criteria for its CLARITY trial to accelerate patient intake, aiming to keep the overall study on track.